Bianchini G, Malorni L, Caputo R, Zambelli A, et al. Role of ctDNA in predicting the outcome of patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with first-line ribociclib and letrozole: BioItaLEE trial. Clin Cancer Res 2026 Jan 26. doi: 10.1158/1078-0432.CCR-25-0650.
PMID: 41587113